Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1261024.RAawGwR5Q5otS-3jovyl-_ieK8A9huUcwTarHztiPa6uA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1261024.RAawGwR5Q5otS-3jovyl-_ieK8A9huUcwTarHztiPa6uA130_assertion type Assertion NP1261024.RAawGwR5Q5otS-3jovyl-_ieK8A9huUcwTarHztiPa6uA130_head.
- NP1261024.RAawGwR5Q5otS-3jovyl-_ieK8A9huUcwTarHztiPa6uA130_assertion description "[Targeted delivery of antisense-miR-21 and antisense-miR-10b coloaded urokinase plasminogen activator receptor (uPAR) targeted polymer NPs treated mice showed substantial reduction in tumor growth at very low dose of 0.15 mg/kg, compared to the control NPs treated mice and 40% reduction in tumor growth compared to scramble peptide conjugated NPs treated mice, thus demonstrating a potential new therapeutic option for TNBC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1261024.RAawGwR5Q5otS-3jovyl-_ieK8A9huUcwTarHztiPa6uA130_provenance.
- NP1261024.RAawGwR5Q5otS-3jovyl-_ieK8A9huUcwTarHztiPa6uA130_assertion evidence source_evidence_literature NP1261024.RAawGwR5Q5otS-3jovyl-_ieK8A9huUcwTarHztiPa6uA130_provenance.
- NP1261024.RAawGwR5Q5otS-3jovyl-_ieK8A9huUcwTarHztiPa6uA130_assertion SIO_000772 25652012 NP1261024.RAawGwR5Q5otS-3jovyl-_ieK8A9huUcwTarHztiPa6uA130_provenance.
- NP1261024.RAawGwR5Q5otS-3jovyl-_ieK8A9huUcwTarHztiPa6uA130_assertion wasDerivedFrom befree-2016 NP1261024.RAawGwR5Q5otS-3jovyl-_ieK8A9huUcwTarHztiPa6uA130_provenance.
- NP1261024.RAawGwR5Q5otS-3jovyl-_ieK8A9huUcwTarHztiPa6uA130_assertion wasGeneratedBy ECO_0000203 NP1261024.RAawGwR5Q5otS-3jovyl-_ieK8A9huUcwTarHztiPa6uA130_provenance.